Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kaehler

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 19, 2013
Sonographic discrimination between benign and malignant adnexal masses in premenopauseM P Radosa, J Vorwergk, J Fitzgerald, et al.
Annals of the Royal College of Surgeons of England|October 19, 2011
Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUMF Egberts, C Hartje, C Schafmayer, et al.
Cancer|July 11, 2008
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 studyAxel Hauschild, Reinhard Dummer, Selma Ugurel, et al.
Melanoma Research|July 16, 2008
Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanomaAxel Hauschild, Uwe Trefzer, Claus Garbe, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 28, 2002
Multicentre study of fetal cardiac time intervals using magnetocardiographyJ Stinstra, E Golbach, P van Leeuwen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsSimone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanomaReinhard Dummer, Axel Hauschild, Juergen C Becker, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
eHealth Literacy in German Skin Cancer PatientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2016
Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patientsCarmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Molecular Psychiatry|March 29, 2017
Prefrontal gray matter volume mediates genetic risks for obesityN Opel, R Redlich, C Kaehler, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 19, 2013
Sonographic discrimination between benign and malignant adnexal masses in premenopauseM P Radosa, J Vorwergk, J Fitzgerald, et al.
Annals of the Royal College of Surgeons of England|October 19, 2011
Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUMF Egberts, C Hartje, C Schafmayer, et al.
Cancer|July 11, 2008
Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 studyAxel Hauschild, Reinhard Dummer, Selma Ugurel, et al.
Melanoma Research|July 16, 2008
Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanomaAxel Hauschild, Uwe Trefzer, Claus Garbe, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 28, 2002
Multicentre study of fetal cardiac time intervals using magnetocardiographyJ Stinstra, E Golbach, P van Leeuwen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patientsSimone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanomaReinhard Dummer, Axel Hauschild, Juergen C Becker, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
eHealth Literacy in German Skin Cancer PatientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2016
Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patientsCarmen Loquai, Dagmar Dechent, Marlene Garzarolli, et al.
Molecular Psychiatry|March 29, 2017
Prefrontal gray matter volume mediates genetic risks for obesityN Opel, R Redlich, C Kaehler, et al.
Pageof 3